NCT05863572

Brief Summary

Background: Mental health services are most effective and equitable when designed, delivered, and evaluated in collaboration with people with lived experience of mental health conditions. Unfortunately, people with lived experience are rarely involved in health systems strengthening or are limited to specific components (e.g., peer helpers) rather than multi-tiered collaboration in the continuum of health services (e.g., ranging from home- to community- to clinic-based services). Moreover, programs that do involve people with lived experience, typically involve people with a history of a substance use conditions or common mental disorders. In contrast, the collaboration of people with lived experience of psychosis is especially rare. A pilot cluster randomized controlled trial will be conducted in urban and peri-urban areas around Kampala, Uganda, to evaluate the benefits of an implementation strategy for mental health services with engagement of people with lived experience of psychosis throughout the home-to-community-to-clinic care continuum, this is a hybrid type-III implementation-effectiveness pilot focusing on the differences in implementation strategy. This implementation strategy, entitled "Strengthening CAre in collaboration with People with lived Experience of psychosis in Uganda", will include training people with lived experience of psychosis using PhotoVoice and other methods to participate at three levels: in-home services, community engagement, and primary health care facilities. The investigators will compare a standard task-sharing implementation arm using training by mental health specialists with an experimental implementation arm that includes collaboration with people with lived experience. The primary objective is to evaluate the feasibility and acceptability of this strategy in the context of assuring safety and wellbeing of people with lived experience of psychosis who collaborate in health systems strengthening. By collaborating on health systems strengthening across these multiple levels, we foresee a more in-depth contribution that can lead to rethinking how best to design and deliver care for people with lived experience of psychosis. Successful completion of this pilot will be the foundation for a fully powered trial to evaluate the benefits of multi-level collaboration with people with lived experience of psychosis.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
132

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 12, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 18, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

September 5, 2023

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

June 19, 2025

Status Verified

June 1, 2025

Enrollment Period

2.6 years

First QC Date

April 12, 2023

Last Update Submit

June 17, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Positive and Negative Symptoms of Schizophrenia (PANSS) scale

    Symptoms of Psychosis, minimum = 0, maximum = 56, higher score is worse

    baseline - immediately after enrollment

  • Positive and Negative Symptoms of Schizophrenia (PANSS) scale

    Symptoms of Psychosis, minimum = 0, maximum = 56, higher score is worse

    4 months post enrollment

  • Positive and Negative Symptoms of Schizophrenia (PANSS) scale

    Symptoms of Psychosis, minimum = 0, maximum = 56, higher score is worse

    8 months post enrollment

Secondary Outcomes (42)

  • World Health Organization Quality of Life-Brief Scale

    immediately after enrollment

  • World Health Organization Quality of Life-Brief Scale

    4 months post enrollment

  • World Health Organization Quality of Life-Brief Scale

    8 months post enrollment

  • Service user collaboration checklist

    immediately after enrollment

  • Service user collaboration checklist

    4 months post enrollment

  • +37 more secondary outcomes

Study Arms (2)

Treatment as usual

ACTIVE COMPARATOR

Training primary care workers in diagnosis and treatment; training community health workers in detection and referral.

Other: Primary care health worker trainingOther: Community Health Workers Training

Strengthening care in collaboration with people with lived experience of psychosis in Uganda

EXPERIMENTAL

Trainings done in collaboration with people with lived experience of psychosis; as well as additional home visits conducted by people with lived experience of psychosis.

Other: Primary care health worker trainingOther: Community Health Workers TrainingOther: Home visits

Interventions

Training primary care workers to detect and treat psychosis.

Strengthening care in collaboration with people with lived experience of psychosis in UgandaTreatment as usual

training community health workers in detection and referral

Strengthening care in collaboration with people with lived experience of psychosis in UgandaTreatment as usual

home visits conducted by people with lived experience of psychosis

Strengthening care in collaboration with people with lived experience of psychosis in Uganda

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Facilitators of the implementation strategy:
  • At least 18 years of age
  • Confirmed diagnosis of a primary psychotic disorder (e.g., schizophrenia) by a psychiatrist or psychiatric clinical officer
  • Completion of the YouBelongHOME (YBH) program
  • Provision of informed consent,
  • Fluency in the local language (Luganda)
  • Good functioning with respect to performance of daily chores,engagement with family members, comprehension and community participation as assessed by the YBH team
  • A supportive family member.
  • Primary care providers:
  • Provides primary care in health facility of Kampala/Wakiso District
  • Selected by facility in-charge
  • Community health workers
  • Provides community based health service in health facility where primary care providers are trained (from Kampala/Wakiso district)
  • Selected by facility in-charge
  • Patients (Primary beneficiaries)
  • +4 more criteria

You may not qualify if:

  • Facilitators of the implementation strategy:
  • a. Inability to provide informed consent.
  • Primary care providers:
  • None
  • Community health workers:
  • None
  • Patients
  • Persons diagnosed with psychosis requiring inpatient management/services; and
  • Persons for whom consent for participation in the study cannot be obtained.
  • Patients found to be severely ill beyond the capacity of the health facility to treat.
  • Family members a. Family members who doesn't provide consent for participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

YouBelong Uganda

Kampala, 99999, Uganda

RECRUITING

Related Publications (1)

  • Mutamba BB, Rai S, Semakula L, Cappo D, Asher L, Gwaikolo W, Kohrt BA. Strengthening care in collaboration with people with lived experience of psychosis in Uganda (SCAPE-U): A protocol for a cluster randomized controlled feasibility trial. Pilot Feasibility Stud. 2025 Jul 21;11(1):103. doi: 10.1186/s40814-025-01684-8.

MeSH Terms

Conditions

Psychotic Disorders

Interventions

House Calls

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Professional PracticeOrganization and AdministrationHealth Services Administration

Study Officials

  • Brandon Kohrt, MD, PhD

    George Washington University

    PRINCIPAL INVESTIGATOR
  • Byamah Mutamba, MD, PhD

    YouBelong Uganda

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Brandon A Kohrt, MD, PhD

CONTACT

Sauharda Rai, MA,PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants and outcome assessors are masked to study arm.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Cluster randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 12, 2023

First Posted

May 18, 2023

Study Start

September 5, 2023

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

June 19, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

There is not a plan to make IPD available. No plan for feasibility study.

Locations